Evidence map›Paper›PMID 27387967›Full record

ArticleHepatology (Baltimore, Md.)2016

Hypothalamic kappa opioid receptor mediates both diet-induced and melanin concentrating hormone-induced liver damage through inflammation and endoplasmic reticulum stress.

Monica Imbernon, Estrella Sanchez-Rebordelo, Amparo Romero-Picó, Imre Kalló, Melissa J Chee, Begoña Porteiro, Omar Al-Massadi, Cristina Contreras, Johan Fernø, Ana Senra and 9 more

Open access · hybridAbstract read
In one paragraph

Article in Hepatology (Baltimore, Md.), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
3.2field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 9 institutions in 5 countries.

Monica ImbernonDepartment of Physiology, CIMUS, University of Santiago de Compostela-Instituto de Investigación Sanitaria.
Estrella Sanchez-RebordeloDepartment of Physiology, CIMUS, University of Santiago de Compostela-Instituto de Investigación Sanitaria.
Amparo Romero-PicóDepartment of Physiology, CIMUS, University of Santiago de Compostela-Instituto de Investigación Sanitaria.
Imre KallóLaboratory of Endocrine Neurobiology, Institute of Experimental Medicine, Hungarian Academy of Sciences, Budapest, Hungary.
Melissa J CheeDivision of Endocrinology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.
Begoña PorteiroDepartment of Physiology, CIMUS, University of Santiago de Compostela-Instituto de Investigación Sanitaria.
Omar Al-MassadiDepartment of Physiology, CIMUS, University of Santiago de Compostela-Instituto de Investigación Sanitaria.
Cristina ContrerasDepartment of Physiology, CIMUS, University of Santiago de Compostela-Instituto de Investigación Sanitaria.
Johan FernøDepartment of Clinical Science, KG Jebsen Center for Diabetes Research, University of Bergen, Bergen, Norway.
Ana SenraDepartment of Physiology, CIMUS, University of Santiago de Compostela-Instituto de Investigación Sanitaria.
Rosalia GallegoDepartment of Morphological Sciences, School of Medicine, University of Santiago de Compostela-Instituto de Investigación Sanitaria.
Cintia FolgueiraDepartment of Physiology, CIMUS, University of Santiago de Compostela-Instituto de Investigación Sanitaria.
Luisa M SeoaneCIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Santiago de Compostela, Spain.
Margriet van GestelDepartment of Neuroscience and Pharmacology, Rudolf Magnus Institute of Neuroscience, University Medical Center Utrecht, Utrecht, The Netherlands.
Roger A AdanDepartment of Neuroscience and Pharmacology, Rudolf Magnus Institute of Neuroscience, University Medical Center Utrecht, Utrecht, The Netherlands.
Zsolt LipositsLaboratory of Endocrine Neurobiology, Institute of Experimental Medicine, Hungarian Academy of Sciences, Budapest, Hungary.
Carlos DieguezDepartment of Physiology, CIMUS, University of Santiago de Compostela-Instituto de Investigación Sanitaria.
Miguel LópezDepartment of Physiology, CIMUS, University of Santiago de Compostela-Instituto de Investigación Sanitaria.
Ruben NogueirasDepartment of Physiology, CIMUS, University of Santiago de Compostela-Instituto de Investigación Sanitaria. ruben.nogueiras@usc.es.
Instituto de Investigación Sanitaria de Santiago · ESUniversidade de Santiago de Compostela · ESCentro de Investigación Biomédica en Red · ESServicio Gallego de Salud · ESUniversity Medical Center Utrecht · NLBeth Israel Deaconess Medical Center · USHungarian Academy of Sciences · HUHUN-REN Institute of Experimental Medicine · HUUniversity of Bergen · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

unlabelledThe opioid system is widely known to modulate the brain reward system and thus affect the behavior of humans and other animals, including feeding. We hypothesized that the hypothalamic opioid system might also control energy metabolism in peripheral tissues. Mice lacking the kappa opioid receptor (κOR) and adenoviral vectors overexpressing or silencing κOR were stereotaxically delivered in the lateral hypothalamic area (LHA) of rats. Vagal denervation was performed to assess its effect on liver metabolism. Endoplasmic reticulum (ER) stress was inhibited by pharmacological (tauroursodeoxycholic acid) and genetic (overexpression of the chaperone glucose-regulated protein 78 kDa) approaches. The peripheral effects on lipid metabolism were assessed by histological techniques and western blot. We show that in the LHA κOR directly controls hepatic lipid metabolism through the parasympathetic nervous system, independent of changes in food intake and body weight. κOR colocalizes with melanin concentrating hormone receptor 1 (MCH-R1) in the LHA, and genetic disruption of κOR reduced melanin concentrating hormone-induced liver steatosis. The functional relevance of these findings was given by the fact that silencing of κOR in the LHA attenuated both methionine choline-deficient, diet-induced and choline-deficient, high-fat diet-induced ER stress, inflammation, steatohepatitis, and fibrosis, whereas overexpression of κOR in this area promoted liver steatosis. Overexpression of glucose-regulated protein 78 kDa in the liver abolished hypothalamic κOR-induced steatosis by reducing hepatic ER stress.

conclusionsThis study reveals a novel hypothalamic-parasympathetic circuit modulating hepatic function through inflammation and ER stress independent of changes in food intake or body weight; these findings might have implications for the clinical use of opioid receptor antagonists. (Hepatology 2016;64:1086-1104).

Indexed as

DietEndoplasmic Reticulum StressAnimalsHypothalamic HormonesHypothalamusInflammationLiver DiseasesMelaninsMiceMice, Inbred C57BLPituitary HormonesRatsRats, Sprague-DawleyReceptors, Opioid, kappaHypothalamic Hormonesmelanin-concentrating hormoneMelaninsPituitary HormonesReceptors, Opioid, kappa

Identifiers

PMID27387967
PMCPMC5129461
OpenAlexW2476273001

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.